Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
41.45
-0.50 (-1.19%)
May 21, 2026, 3:00 PM CST

SHA:600329 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
902.121,0162,9442,1252,8832,283
Short-Term Investments
865.683,3161,00061.740.61109.64
Cash & Short-Term Investments
1,7684,3323,9452,1872,9232,393
Cash Growth
19.71%9.84%80.37%-25.19%22.16%20.40%
Accounts Receivable
1,7971,5711,3162,6532,7251,971
Other Receivables
10.5810.298.5634.160.7740.73
Receivables
1,8081,6051,3252,6872,7852,011
Inventory
1,0781,1331,2861,5671,4291,525
Other Current Assets
1,46284.5752.96111.07107.5495.77
Total Current Assets
6,1167,1556,6086,5527,2456,425
Property, Plant & Equipment
1,1311,1411,3931,4421,4651,486
Long-Term Investments
1,1722,5932,065882.67801.46740.74
Goodwill
--12.365.9184.69-
Other Intangible Assets
288.69292.75295.29317.75281.13198.19
Long-Term Deferred Tax Assets
368.27341.01314.4265.99208.35154.6
Long-Term Deferred Charges
57.0352.8366.0718.317.544.72
Other Long-Term Assets
1,303114.3313.56686.2953.7757.51
Total Assets
10,43611,69010,76910,23010,1579,067
Accounts Payable
238.1189.19233.741,1261,4061,242
Accrued Expenses
2341,9171,8241,4931,170679.77
Short-Term Debt
47.5657.921.6581.8101.64-
Current Portion of Long-Term Debt
-----30
Current Portion of Leases
4.383.121.333.564.11.6
Current Income Taxes Payable
213.129.22297.5776.6893.289.53
Current Unearned Revenue
101.97150.19123.56145.66219.07215.61
Other Current Liabilities
1,9902,160315.64305.66339.37254.89
Total Current Liabilities
2,8294,5062,8183,2333,3332,434
Long-Term Debt
-1010251.03161.310
Long-Term Leases
5.914.665.62.740.871.57
Long-Term Unearned Revenue
45.4845.4955.1457.1459.8859.15
Long-Term Deferred Tax Liabilities
0.240.286.047.338.824.21
Other Long-Term Liabilities
32.9322.9324.0733.6940.7344.42
Total Liabilities
2,9144,5902,9193,5853,6052,553
Common Stock
770.09770.09770.09770.16773.44773.44
Additional Paid-In Capital
974.98974.98974.79975.211,0481,374
Retained Earnings
5,7545,3306,0724,8284,7004,218
Treasury Stock
----7.04-29.75-32.03
Comprehensive Income & Other
23.1524.0726.9334.3429.5330.62
Total Common Equity
7,5227,0997,8446,6016,5216,364
Minority Interest
-0.290.456.3444.5530.49149.35
Shareholders' Equity
7,5227,1007,8506,6456,5526,514
Total Liabilities & Equity
10,43611,69010,76910,23010,1579,067
Total Debt
57.8475.6838.59339.14267.9143.17
Net Cash (Debt)
1,7104,2573,9061,8482,6552,350
Net Cash Growth
22.33%8.98%111.39%-30.41%13.01%20.83%
Net Cash Per Share
2.225.535.062.403.423.05
Filing Date Shares Outstanding
770.09767.09770.09770.16773.44773.44
Total Common Shares Outstanding
770.09767.09770.09770.16773.44773.44
Working Capital
3,2872,6483,7903,3193,9123,991
Book Value Per Share
9.779.2610.198.578.438.23
Tangible Book Value
7,2346,8077,5366,2176,1566,166
Tangible Book Value Per Share
9.398.879.798.077.967.97
Buildings
-1,0991,3251,3381,3371,323
Machinery
-1,0481,0661,1071,0871,028
Construction In Progress
-391.01436.35386.46333.85331.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.